Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer’s Disease

The clinical diagnosis and treatment of Alzheimer’s disease (AD) represent a challenge to clinicians due to the variability of clinical symptomatology as well as the unavailability of reliable diagnostic tests. In this study, the development of a novel electrochemical assay and its potential to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Garyfallou, Goulielmos-Zois, Ketebu, Orlando, Şahin, Samet, Mukaetova-Ladinska, Elizabeta B., Catt, Michael, Yu, Eileen Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713623/
https://www.ncbi.nlm.nih.gov/pubmed/29077013
http://dx.doi.org/10.3390/s17112464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713623/
https://www.ncbi.nlm.nih.gov/pubmed/29077013
http://dx.doi.org/10.3390/s17112464

Ejemplares similares